Topic

Emma Palmer Foster is a Director at Discovery Park Ventures.

Articles

Start-ups are plagued with common issues that dramatically decrease their odds of achieving investor funding.

Mike Hennessy Jr. is the President and CEO of 

The debate surrounding drug pricing changes rages on.

Chris Spivey is the editorial director of 

BIO is a powerful business development conference that can help make a lot of deals become reality.

Susan Haigney is managing editor of BioPharm International, susan.haigney@ubm.com.

The bio/pharma outsourcing industry continues to be integral in the development and manufacture of medicines. 

B.S Sathya Durga is Director at Acute Market Reports.

Guest contributor B.S. Sathya Durga discusses the importance of modernizing India's pharmaceutical manufacturing industry.

Frédéric Kahn is Generic APIs Commercial Head at Seqens.

Guest contributor Frederic Kahn discusses the state of the Indian pharmaceutical manufacturing industry.

Researchers from the Telomere-to-Telomere Consortium have discovered new properties about junk DNA that could have wide-reaching implications.

The process of reshaping inevitably leads to fresh insights.

Change of roster does not change the goal line. We are all patients first.

Rita C. Peters is the former editorial director of 

The mission continues. Let science be the guide.